🇺🇸 United States market recap
Risk-on2026-06-20😱 Moderate greed: easing oil shock fears, but rich valuations keep volatility elevated.
U.S. equities are still in a constructive but selective **risk-on** tape: broad indexes have held near highs, but leadership is narrowing around AI, semis, and deal-driven names 📈🤖🌍. The latest lift came from easing Middle East oil-risk fears after a U.S.-Iran interim peace agreement and from still-resilient earnings expectations, even as the Fed stayed cautious and signaled policy could remain restrictive. Valuations remain rich, so sector selection matters more than broad beta.
Big news
📰 U.S.-Iran interim peace agreement reopened the Strait of Hormuz
Reduced oil-supply shock risk; helped cyclicals, transports, and rates-sensitive growth.
📰 Federal Reserve held rates steady, with some officials still signaling a possible hike this year
Keeps duration pressure on rate-sensitive sectors and caps multiple expansion.
📰 Intel jumped after Trump said it would make chips for Apple in the U.S.
Boosted semis and domestic-capex themes; positive for foundry and U.S. manufacturing.
📰 Nvidia and Micron rallied alongside the broader chip complex
Confirms AI/semiconductor leadership remains the market’s key growth engine.
📰 SpaceX IPO became the largest public listing in history
Strengthened innovation sentiment across aerospace, defense-tech, and AI-adjacent growth.
📰 Consensus now projects S&P 500 earnings growth of 23% in 2026 and 16% in 2027
Supports equities broadly, but leaves little room for disappointments in high-multiple sectors.
Sector stance
AI/semis lead; Intel, Nvidia, Micron show strong tape and capex momentum.
Platform ad spend and AI optionality remain supportive; leadership is concentrated.
U.S. reshoring, aerospace, and defense-tech benefit from policy and deal activity.
Oil-risk eased after Iran deal; still sensitive to geopolitics and crude swings.
Stable rates help margins, but hawkish Fed limits upside and loan growth.
Defensive support offset by mixed earnings; selective in pharma and tools.
Resilient spending, but valuation and rate sensitivity argue for selectivity.
Defensive but lagging in a risk-on tape; limited earnings acceleration.
Yield proxy faces pressure if rates stay elevated and yields firm.
Lower yields help, but a cautious Fed and rich multiples cap upside.
Copper and AI infrastructure demand help, but China-linked demand remains uneven.
Outlook
The market remains supported by earnings momentum, AI capital spending, and lower geopolitical stress, but elevated valuations mean leadership should stay narrow. If yields drift higher again or oil spikes, defensives and energy regain appeal; if rates stay contained, semis, software, and industrial AI beneficiaries should outperform. Investors should lean into **quality growth with domestic policy tailwinds** and keep exposure flexible around rates and crude.